Global Ketamine API Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Ketamine API Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Ketamine API refers to the raw material drug used in the production of Ketamine preparations, which is the active ingredient in the preparations.

Market Overview:

The latest research study on the global Ketamine API market finds that the global Ketamine API market reached a value of USD 40.22 million in 2022. It’s expected that the market will achieve USD 156.75 million by 2028, exhibiting a CAGR of 25.45% during the forecast period.

Influence of Regional Conflicts on the Ketamine API Industry

The impact of the Russo-Ukraine war has extended from the military to energy, food, currency, trade, international politics, and other aspects. The Russia-Ukraine region is an important exporter of global energy raw materials, industrial raw materials, corn, wheat, barley, and other food materials. The continuation of the Russo-Ukraine war has continued to promote large fluctuations in the prices of various fuels and raw materials, directly increasing the cost of production and sales in many industries. For the Ketamine API industry, on the one hand, due to the outbreak of war, the price of natural gas and other energy sources has risen, resulting in an increase in energy costs for production. On the other hand, the rise in natural gas prices has also led to an increase in logistics costs during the sales of Ketamine API.

Drivers

Multi-field application of ketamine drug
Ketamine is a versatile drug whose unique properties allow it to be used worldwide in different clinical scenarios. It can be used as a general anesthesia induction drug with very stable hemodynamics at high doses, and a very reliable sedative and analgesic drug at low doses. Its use plays a very important role in pre-hospital first aid and emergency department. Use as a co-drug in routine anesthesia can reduce postoperative opioid use. Used in the intensive care unit as a sedative and as a treatment for refractory asthma.

Region Overview:

In 2022, the share of the Ketamine API market in United States stood at 61.06%.

Company Overview:

Supriya Lifescience Ltd. has a solid position in the API manufacturing field, focusing on products in various therapeutic areas such as antihistamines, antiallergics, vitamins, anesthetics, anti-asthmas, etc. The company prides itself on delivering quality products by setting products, processes and systems to industry standards and continually improving them. The company's focus is on the development of APIs and intermediates for innovators and generic pharmaceutical companies.

SEQENS is a global leader in pharmaceutical solutions and specialty ingredients. The group operates 24 manufacturing plants and 10 R&D centers in Europe, North America and Asia. SEQENS is an integrated company offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. The company develops and industrializes the most demanding molecules and relies on the company's ability to innovate, develop and implement the best available technologies.

Supriya Lifescience is one of the major players operating in the Ketamine API market, holding a share of 37.34% in 2022.

Segmentation Overview:

As for product types, the Esketamine Hydrochloride segment held the largest market share in 2022.

Application Overview:

The market's largest segment by application is the segment Anti-depressant, with a market share of 60.99% in 2022.

Key Companies in the global Ketamine API market covered in Chapter 3:

Supriya Lifescience
Bnm Organics
SEQENS
Arevipharma GmbH
Maithri Drugs
Midas Pharma

In Chapter 4 and Chapter 14.2, on the basis of types, the Ketamine API market from 2018 to 2029 is primarily split into:

Ketamine Hydrochloride
Esketamine Hydrochloride

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Ketamine API market from 2018 to 2029 covers:

Analgesic & Anesthetic
Anti-depressant

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)